A proof-of-concept study by the ECOG-ACRIN Cancer Research Group measured circulating tumor cells (CTCs) in blood samples from patients cancer-free five years after diagnosis, then associated CTC presence with a later recurrence ECOG-ACRIN CANCER RESEARCH GROUP A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to...
Tag: <span>Breast Cancer</span>
Post
Over-the-counter supplement found on the High Street reduces breast cancer aggressiveness by up to 80%, breakthrough study finds
NAC, approved for colds, lowers levels of cancer aggressiveness marker MCT4 MCT4 is reduced by 80%, while the aggressive marker Ki67 decreases by 25% Drug contains antioxidants that make tumors release nutrients, stopping growth Low-toxicity treatment as its acceptable side effects have been shown in colds Researchers from the University of Salford analysed 12 breast cancer...
Post
Two breast cancer drugs get NHS approval
Two breast cancer drugs have been recommended for use by the NHS in England. In draft guidance, the National Institute for Health and Care Excellence (NICE) has approved palbociclib (Ibrance) and ribociclib (Kisqali) for patients with advanced breast cancer. The drugs are thought to slow the growth of the disease and delay the need for other treatments. Cancer...
Post
UVA researchers discover a new target for ‘triple-negative’ breast cancer
So-called “triple-negative” breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities. Triple-negative breast cancer earns its name because, unlike other breast cancer subtypes, its cells test negative for estrogen and progesterone receptors, as...
Post
Breast cancer recurrence risk lingers years after treatment ends
Daniel F. Hayes, M.D. Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators published in the New England Journal of Medicine. Standard treatment for estrogen receptor-positive, or...
Post
Epigenetic editing reveals surprising insights into early breast cancer development
Micrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to begin a chain reaction and become abnormal, according to research by Queen Mary University of London (QMUL). The...
Post
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue. Nearly half of all women in the U.S. have dense breast tissue. “Women who have dense breasts...
Post
‘Baking soda can cure breast cancer and mammograms cause it’: Charity reveals 10 myths about the disease as it appoints first digital ‘fake news’ nurse to deal with growing problem
Macmillan Cancer Support reveals 10 of the inaccurate beliefs circulating online Another false theory is that cancer sufferers should not eat sugar People also believe that having a mammograms will give you cancer The charity has appointed its first ‘digital nurse to combat ‘fake news’ Baking soda can cure breast cancer and deodorants and underwire bras can cause...
Post
How does excess weight drive breast cancer? Study sheds light
Obesity is a known risk factor for breast cancer, but precisely how does excess weight drive the disease? A new study has shed some light, revealing the process by which obesity increases the aggression of breast cancer cells. Researchers reveal how obesity may promote breast cancer metastasis. By studying mouse and human breast cancer tissue, researchers discovered...
Post
Major study of genetics of breast cancer provides clues to mechanisms behind the disease
MONTRÉAL, Oct. 23, 2017 /CNW Telbec/ – Seventy-two new genetic variants that contribute to the risk of developing breast cancer have been identified by a major international collaboration involving hundreds of researchers worldwide. The studies reported today in the journals Nature and Nature Genetics identified 72 common variants that predispose to breast cancer. Among these genetic regions some are specifically associated with...